Taxanes and gemcitabine doublets in the management of HER-2 negative metastatic breast cancer: towards optimization of association and schedule.Giulio Metro, Paolo Carlini, Michelino De Laurentiis et al.|PubMed|2008Cited by 11
Individualized administration of capecitabine plus lapatinib in heavily pretreated HER2+ metastatic breast cancer patients: A single-center experience.Paola Papaldo, F. Cognetti, Giulio Metro et al.|Journal of Clinical Oncology|2010Cited by 0